Ledger.Open graph →
SEC Form D · filed January 24, 2018

TheraPten Biosciences Inc

Offering
$500K
Sold
$500K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
KELOWNA, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Athanasios Alevizopoulos · Yverdon-les-Bains, V8Exec · DirectorHarvey Lalach · Kelowna, British Columbia, CanadaExec · DirectorYiannis Monovoukas · Weston, MADirectorRobert Waley-Cohen · New York, NYDirectorNicholas Bearsted · New York, NYExec · DirectorKyriakoulis Paganis · Anavyssos, J3DirectorMarc C. Pollack · Atlanta, GAExec · DirectorSteven Shores · Atlanta, GADirectorHarvey Lalach · Kelowna, British Columbia, CanadaExec · DirectorKyriakoulis Paganis · Anavyssos, J3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗